Sarcoma
Trabectedin or Dacarbazine Advanced L-Sarcoma (20110545)
A Randomized Controlled Study of YONDELIS (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide
Investigator: Robin L. Jones, MD; Conditions: Liposarcoma, Leiomyosarcoma; Status: Recruiting; Study ID: NCT01343277
A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Investigator: Robin Jones, MD; Conditions: Sarcoma; Status: Recruiting; Study ID: NCT01440088
A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung
Investigator: Robin L. Jones, MD; Conditions: Osteosarcoma; Status: Recruiting; Study ID: NCT00923286
European Ewing Tumor Working Initiative of National Groups Ewing Tumour Studies 1999 (EURO-E.W.I.N.G. 99)
Investigator: Doug Hawkins, MD; Conditions: Sarcoma; Solid Tumors; Status: Recruiting; Study ID: NCT00020566
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS)
Investigator: Doug Hawkins, MD; Conditions: Sarcoma; Solid Tumors; Status: Recruiting; Study ID: NCT00354835
A Multicenter, Open-label Single-arm Study of YONDELIS® (trabectedin) for Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment
Investigator: Robin L. Jones, MD; Conditions: Sarcoma; Status: Recruiting; Study ID: NCT00210665
Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)
Investigator: Doug Hawkins, MD; Conditions: Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma; Status: Recruiting; Study ID: NCT00346164
A Phase I/II Study of Lenalidomide in Patients with AIDS-Associated Kaposi's Sarcoma
Investigator: Corey Casper; Conditions: Sarcoma; Status: Recruiting; Study ID: NCT01057121
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma
Investigator: Robin L. Jones, MD; Conditions: Soft Tissue Sarcoma; Status: Recruiting; Study ID: NCT01327885
The Effect of Antiangiogenic Therapy With Pazopanib Prior to Preoperative Chemotherapy for Subjects With Extremity Soft Tissue Sarcomas: A Randomized Study to Evaluate Response by Imaging
Investigator: Robin L. Jones, MD; Conditions: Soft tissue sarcoma; Status: Recruiting; Study ID: NCT01446809
A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Docetaxel in Patients With Advanced Malignant Solid Tumors
Investigator: Laura Q.M. Chow, MD; Conditions: Malignant Solid Tumor; Status: Closed; Study ID: NCT01567163
A Study to Evaluate the Potential of Concomitant Ramucirumab to Affect the Pharmacokinetics of Paclitaxel in Patients With Advanced Malignant Solid Tumors
Investigator: Laura Q.M. Chow, MD; Conditions: Malignant Solid Tumor; Status: Closed; Study ID: NCT01515306
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel in Metastatic Soft Tissue Sarcoma
Investigator: Robin L. Jones, MD; Conditions: Metastatic Soft Tissue Sarcoma; Status: Recruiting; Study ID: NCT01574716
A Multi-arm Dose-finding Phase Ib Multicenter Study of Imatinib in Combination With the Oral Phosphatidyl-inositol 3-kinase (PI3-K) Inhibitor BKM120 in Patients With Gastrointestinal Stromal Tumor (GIST) Who Failed Prior Therapy With Imatinib and Sunitinib
Investigator: Robin L. Jones, MD; Conditions: 3rd Line GIST; Status: Recruiting; Study ID: NCT01468688
Join Us On